← Back to headlines
Zelluna Receives Recommendation to Continue Patient Enrollment in ZIMA-101 Trial
Zelluna has announced that its Independent Data Monitoring Committee has recommended the continuation of patient enrollment in its ZIMA-101 clinical trial.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia
45m ago
Five Teenagers Die in Ireland Driving Wrong Way on Motorway for Social Media Trend
45m ago
Metro Manila Inundated by Heavy Monsoon Rains
2h ago
Hayden Panettiere's Life and Career Remembered Amidst Personal Struggles
3h ago